Cadus Pharmaceutical Corp. (KDUS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)

KDUS 1.600

0.0%

Jul 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Geigartt who wrote (308)	10/2/2000 3:01:42 PM
From: RCMac	Read Replies (1) of 1833

>>Anybody else knowledgeable enough to value the Axion [Axiom] share? << No, no one. We haven't been told enough by KDUS or anyone else, though not for lack of trying (Rick's, Stefaan's and others'). I did try to put a value on some of the pieces of KDUS in post #219 on this thread: Message 14344049 Stefaan Bafort had earlier, in #208, made a resourceful stab at the Axiom piece: Message 14214616 But we can't really know, because they're not saying. But for my own back-of-the envelope calculations I've been saying the KDUS interest in Axiom is worth somewhere in the $10 million - $50 million range (which is sort of like Rick's $30 million, only less firmly stated). But as I posted earlier, if you use $10 million for the Axiom piece and add the $25 million cash, you get almost $3.00/share on the most static of value-player's calculations, i.e., without adding anything for either (a) any future royalty stream from the OSIP license, or (b) any future deals in which KDUS might leverage its IP. I'll think I'll hold on. -- RCM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next